Cystic fibrosis and alpha-1 antitrypsin deficiency: case report and review of literature.


Journal

BMC pediatrics
ISSN: 1471-2431
Titre abrégé: BMC Pediatr
Pays: England
ID NLM: 100967804

Informations de publication

Date de publication:
03 05 2022
Historique:
received: 29 09 2021
accepted: 19 04 2022
entrez: 3 5 2022
pubmed: 4 5 2022
medline: 6 5 2022
Statut: epublish

Résumé

This case report describes a child born with both cystic fibrosis (CF) and alpha-1 antitrypsin deficiency (A1ATD). Both are autosomal recessive inherited diseases, mainly affecting the lungs and the liver. The combination of both diseases together is rare and may lead to a fulminant disease with limited life span. To the best of our knowledge, no case has been reported of a patient born with both diseases. After an uneventful pregnancy, a male baby was born with meconium ileus. The suspected diagnosis of CF was confirmed based on the sweat test and genetic analysis. The child developed persisting cholestasis, too severe to be likely caused by CF alone and indicating an associated problem. The diagnosis of A1ATD was established based on clinical suspicion (persisting cholestasis), decreased serum alpha-1 antitrypsin and genetic analysis. Supportive therapy was started, however the boy evolved to rapidly progressive liver disease leading to liver failure which necessitated an infant liver transplantation. This case illustrates the complexity of care in case of two severe inherited diseases as well as post solid organ transplant care.

Sections du résumé

BACKGROUND
This case report describes a child born with both cystic fibrosis (CF) and alpha-1 antitrypsin deficiency (A1ATD). Both are autosomal recessive inherited diseases, mainly affecting the lungs and the liver. The combination of both diseases together is rare and may lead to a fulminant disease with limited life span. To the best of our knowledge, no case has been reported of a patient born with both diseases.
CASE PRESENTATION
After an uneventful pregnancy, a male baby was born with meconium ileus. The suspected diagnosis of CF was confirmed based on the sweat test and genetic analysis. The child developed persisting cholestasis, too severe to be likely caused by CF alone and indicating an associated problem. The diagnosis of A1ATD was established based on clinical suspicion (persisting cholestasis), decreased serum alpha-1 antitrypsin and genetic analysis. Supportive therapy was started, however the boy evolved to rapidly progressive liver disease leading to liver failure which necessitated an infant liver transplantation.
CONCLUSIONS
This case illustrates the complexity of care in case of two severe inherited diseases as well as post solid organ transplant care.

Identifiants

pubmed: 35505316
doi: 10.1186/s12887-022-03290-6
pii: 10.1186/s12887-022-03290-6
pmc: PMC9063355
doi:

Types de publication

Case Reports Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

247

Informations de copyright

© 2022. The Author(s).

Références

Pulmonology. 2018 Dec;24 Suppl 1:1-21
pubmed: 30473034
Cell Mol Life Sci. 2017 Jan;74(1):129-140
pubmed: 27709245
J Cyst Fibros. 2009 Dec;8(6):392-9
pubmed: 19733131
J Pediatr Gastroenterol Nutr. 2017 Oct;65(4):443-448
pubmed: 28753176
Ann Am Thorac Soc. 2016 Apr;13 Suppl 2:S191-6
pubmed: 27115956

Auteurs

Evi Jaspers (E)

University Hospital Leuven, Herestraat 49, 3001, Leuven, Belgium.

Ine Van Dijck (I)

University Hospital Leuven, Herestraat 49, 3001, Leuven, Belgium.

Ilse Hoffman (I)

University Hospital Leuven, Herestraat 49, 3001, Leuven, Belgium.

Noël Knops (N)

University Hospital Leuven, Herestraat 49, 3001, Leuven, Belgium.

Xavier Stéphenne (X)

University Hospital Saint-Luc, Avenue Hippocrate 10, 1200, Brussels, Belgium.

Peter Witters (P)

University Hospital Leuven, Herestraat 49, 3001, Leuven, Belgium.

Marijke Proesmans (M)

University Hospital Leuven, Herestraat 49, 3001, Leuven, Belgium. Marijke.proesmans@uzleuven.be.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH